Inventor · disambiguated record
Thomas Ketterer
Also filed as: BAYER LEGAL REPRESENTATIVE INGE · KETTERER THOMAS
25 granted patents·10 pending applications·626 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
35 records- 0198US11433027B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2020·Granted Sep 6, 2022·15 cites·25 claims
- 0298US11179337B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2019·Granted Nov 23, 2021·35 cites·28 claims
- 0398US10729654B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2016·Granted Aug 4, 2020·36 cites·15 claims
- 0497US11760992B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC MFG GMBH·Filed 2022·Granted Sep 19, 2023·7 cites·30 claims
- 0597US11667910B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC MFG GMBH·Filed 2022·Granted Jun 6, 2023·10 cites·26 claims
- 0697US11661634B2Method for producing RNACUREVAC MFG GMBH·Filed 2022·Granted May 30, 2023·7 cites·30 claims
- 0797US11534405B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2020·Granted Dec 27, 2022·11 cites·18 claims
- 0897US11446250B2Lyophilization of RNACUREVAC REAL ESTATE GMBH·Filed 2020·Granted Sep 20, 2022·14 cites·30 claims
- 0997US11274293B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC REAL ESTATE GMBH·Filed 2020·Granted Mar 15, 2022·30 cites·45 claims
- 1097US11268157B2Method for producing RNACUREVAC REAL ESTATE GMBH·Filed 2020·Granted Mar 8, 2022·29 cites·18 claims
- 1197US10837039B2Methods and means for enhancing RNA productionCUREVAC REAL ESTATE GMBH·Filed 2015·Granted Nov 17, 2020·34 cites·18 claims
- 1297US10780054B2Lyophilization of RNACUREVAC REAL ESTATE GMBH·Filed 2016·Granted Sep 22, 2020·44 cites·17 claims
- 1397US10760070B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC REAL ESTATE GMBH·Filed 2016·Granted Sep 1, 2020·47 cites·24 claims
- 1497US10711315B2Method for producing RNACUREVAC REAL ESTATE GMBH·Filed 2018·Granted Jul 14, 2020·28 cites·16 claims
- 1597US10517827B2Dry powder composition comprising long-chain RNACUREVAC AG·Filed 2016·Granted Dec 31, 2019·35 cites·15 claims
- 1696US12318486B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Jun 3, 2025·3 cites·16 claims
- 1796US12138348B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Nov 12, 2024·3 cites·20 claims
- 1896US11834651B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC MFG GMBH·Filed 2023·Granted Dec 5, 2023·3 cites·45 claims
- 1996US11491112B2Lyophilization of RNACUREVAC MFG GMBH·Filed 2021·Granted Nov 8, 2022·12 cites·36 claims
- 2096US10017826B2Method for producing RNACUREVAC AG·Filed 2016·Granted Jul 10, 2018·29 cites·34 claims
- 2195US12221605B2Method for producing and purifying RNA, comprising at least one step of tangential flow filtrationCUREVAC MFG GMBH·Filed 2023·Granted Feb 11, 2025·1 cites·55 claims
- 2295US8383340B2Method for purifying RNA on a preparative scale by means of HPLCCUREVAC GMBH·Filed 2007·Granted Feb 26, 2013·164 cites·26 claims
- 2392US10441653B2Nucleic acid comprising GlXmGn as an immune-stimulating agent/adjuvantHOERR INGMAR·Filed 2012·Granted Oct 15, 2019·29 cites·33 claims
- 2491US2025129359A1Method for producing and purifying rna, comprising at least one step of tangential flow filtrationCUREVAC MFG GMBH·Filed 2024·Application pending·0 cites
- 2587US2025114307A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 2686US2025099388A1Lyophilization of rnaCUREVAC MFG GMBH·Filed 2024·Application pending·0 cites
- 2785US2024218412A1Methods and means for enhancing rna productionCUREVAC MFG GMBH·Filed 2024·Application pending·0 cites
- 2885US2025195436A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 2981US12194148B2Lyophilization of RNACUREVAC MFG GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·20 claims
- 3079US2022154253A1Method for producing rnaCUREVAC REAL ESTATE GMBH·Filed 2022·Application pending·0 cites
- 3171US2021040526A1Methods and means for enhancing rna productionCUREVAC REAL ESTATE GMBH·Filed 2020·Application pending·0 cites
- 3264US2009324584A1Nucleic Acid of Formula (I): GIXmGn, or (II): CIXmCn, in Particular as an Immune-Stimulating Agent/AdjuvantCUREVAC GMBH·Filed 2007·Application pending·0 cites
- 3362US2020016264A1NUCLEIC ACID OF FORMULA (I): GlXmGn, OR (II): ClXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANTCUREVAC AG·Filed 2019·Application pending·0 cites
- 3458US2007280929A1Adjuvant in the form of a lipid-modified nucleic acidCUREVAC GMBH·Filed 2007·Application pending·0 cites
- 3537US7608705B2Oligonucleotides, agents containing these oligonucleotides, and the use thereofUNIVERSITATSKLINIKUM SCHLESWIG·Filed 2001·Granted Oct 27, 2009·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Ketterer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →